News

Dr. Melissa Little, a world leader in stem cell research, successfully developed the first kidney organoid. In advance of her lecture at the Max Delbrück Center, she shares insights about the road to that eureka moment, the journey since and the state of stem cell and organoid research today.

From November 1 to 10, 2024, researchers and science enthusiasts will once again gather in Berlin to discuss current developments and challenges in science, business and society - with each other and with the public. The Max Delbrück Center will once again be contributing exciting events this year, online and on site. Join us!

In a study led by Professor Jan Korbel, Senior Scientist and Head of Data Science at the European...

Cancer treatment has become complex. An AI based online tool developed by researchers at the Max Delbrück Center can already help oncologists and cancer patients find the most up to date personalized treatment.

Every year acute renal failure affects over 13 million people and leads to 1.7 million deaths across the globe.It often develops when an insufficient supply of oxygen reaches the kidneys, a condition called ischemia. Working with their colleagues from the MDC, the Charité and FMP in Berlin and Hannover Medical School, Dr Lajos Markó and Emilia Vigolo have traced one of the causes of ischemia-related renal failure to a signaling molecule called NF-κB and a specific type of tissue: tubular epithelial cells. Suppressing NF-κB signaling in these renal cells almost entirely eliminates the fatal tissue damage and inflammatory responses that accompany the disease.